BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17362443)

  • 1. Lithium intoxication after valsartan treatment.
    Su YP; Chang CJ; Hwang TJ
    Psychiatry Clin Neurosci; 2007 Apr; 61(2):204. PubMed ID: 17362443
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential drug interaction between lithium and valsartan.
    Leung M; Remick RA
    J Clin Psychopharmacol; 2000 Jun; 20(3):392-3. PubMed ID: 10831034
    [No Abstract]   [Full Text] [Related]  

  • 3. Temporal association as a prerequisite factor of valsartan-induced lithium toxicity.
    Lazarczyk MJ; Giannakopoulos P
    Bipolar Disord; 2014 Sep; 16(6):662-6. PubMed ID: 24372930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute renal failure and hypertension].
    Bellido D; Sánchez de la Nieta MD; Vozmediano C; Oteros R; Zarca MA; Nieto J; Rivera F
    Nefrologia; 2005; 25(5):563-7. PubMed ID: 16392308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New effective dosage of valsartan. High dosage--effective against high blood pressure].
    MMW Fortschr Med; 2007 Nov; 149(46):52-3. PubMed ID: 18069195
    [No Abstract]   [Full Text] [Related]  

  • 6. Angiotensin receptor blockers and myocardial infarction: the importance of dosage.
    Sarzani R; Dessì-Fulgheri P
    J Hypertens; 2006 Aug; 24(8):1679-81; author reply 1681-2. PubMed ID: 16877973
    [No Abstract]   [Full Text] [Related]  

  • 7. Angiotensin receptor blockers and myocardial infarction.
    Verma S; Strauss M
    BMJ; 2004 Nov; 329(7477):1248-9. PubMed ID: 15564232
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fetal toxicity of angiotensin-II-receptor inhibitors. Case report].
    Roger N; Popovic I; Madelenat P; Mahieu-Caputo D
    Gynecol Obstet Fertil; 2007 Jun; 35(6):556-60. PubMed ID: 17544313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valsartan-induced drug eruption followed by CD30+ pseudolymphomatous eruption.
    Sawada Y; Yoshiki R; Kawakami C; Fukamachi S; Sugita K; Nakamura M; Tokura Y
    Acta Derm Venereol; 2010 Sep; 90(5):521-2. PubMed ID: 20814632
    [No Abstract]   [Full Text] [Related]  

  • 10. Two amlodipine/ARB combinations for hypertension.
    Med Lett Drugs Ther; 2007 Dec; 49(1276):101-2. PubMed ID: 18084152
    [No Abstract]   [Full Text] [Related]  

  • 11. Second study on valsartan is threatened with retraction over alleged data manipulation.
    Mahony C
    BMJ; 2013 Aug; 347():f4920. PubMed ID: 23918698
    [No Abstract]   [Full Text] [Related]  

  • 12. Fetal toxic effects of angiotensin II receptor antagonists: case report and follow-up after birth.
    Bos-Thompson MA; Hillaire-Buys D; Muller F; Dechaud H; Mazurier E; Boulot P; Morin D
    Ann Pharmacother; 2005 Jan; 39(1):157-61. PubMed ID: 15590878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of antihypertensive therapy with add-on angiotensin II type 1 receptor blocker after successful coronary stent implantation.
    Sugihara M; Miura S; Takamiya Y; Kiya Y; Arimura T; Iwata A; Kawamura A; Nishikawa H; Uehara Y; Saku K
    Hypertens Res; 2009 Jul; 32(7):625-30. PubMed ID: 19461652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vildagliptin, a novel dipeptidyl peptidase IV inhibitor, has no pharmacokinetic interactions with the antihypertensive agents amlodipine, valsartan, and ramipril in healthy subjects.
    He YL; Ligueros-Saylan M; Sunkara G; Sabo R; Zhao C; Wang Y; Campestrini J; Pommier F; Dole K; Marion A; Dole WP; Howard D
    J Clin Pharmacol; 2008 Jan; 48(1):85-95. PubMed ID: 17986525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Valsartan improves symptoms and quality of life in patients with chronic heart failure].
    Baumhäkel M; Müller U; Böhm M
    MMW Fortschr Med; 2008 Apr; 150 Suppl 1():48-53. PubMed ID: 18540333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Scientific evidence--applied in routine general practice. Successful decrease in pressure and risk].
    MMW Fortschr Med; 2006 May; 148(18):42-3. PubMed ID: 16736689
    [No Abstract]   [Full Text] [Related]  

  • 17. Exanthematous drug eruption due to valsartan.
    Ozturk G; Turk BG; Senturk B; Turkmen M; Kandiloglu G
    Cutan Ocul Toxicol; 2012 Dec; 31(4):335-7. PubMed ID: 22257082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telmisartan-induced lithium intoxication in a patient with schizoaffective disorder.
    Ma CC; Shiah IS; Chang SW; Kao YC; Lee WK
    Psychiatry Clin Neurosci; 2012 Mar; 66(2):165-6. PubMed ID: 22353332
    [No Abstract]   [Full Text] [Related]  

  • 19. Angioedema and photosensitive rash induced by valsartan.
    Frye CB; Pettigrew TJ
    Pharmacotherapy; 1998; 18(4):866-8. PubMed ID: 9692664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dilemma of antihypertensive therapy: high blood pressure diminishes, potency sometimes, too].
    MMW Fortschr Med; 2006 Sep; 148(38):17. PubMed ID: 17036956
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.